Volver al
artículo.
Referencias para el artículo
- Weikl A, Noh HS. The influence of Crataegus on global cardiac
insufficiency. Herz Gefabe 1993;11:516–24.
- Loew D. Pharmacological and clinical results with Crataegus special
extracts in cardiac insufficiency. ESCOP Phytotelegram 1994;6:20–6.
- Bahorun T, Trotin F, Pommery J, et al. Antioxidant activities of Crataegus
monogyna extracts. Planta Med 1994;60:323–8.
- Weihmayr T, Ernst E. Therapeutic effectiveness of Crataegus. Fortschr
Med 1996;114:27–9 [in German].
- Schmidt U, Kuhn U, Ploch M, Hübner W-D. Efficacy of the Hawthorn
(Crataegus) preparation LI 132 in 78 patients with chronic congestive heart failure defined as
NYHA functional class II. Phytomed 1994;1:17–24.
- Leuchtgens H. Crataegus special extract WS 1442 in heart failure, NYHA II. A
placebo-controlled randomized double-blind study. Fortschr Med
1993;111:352–4.
- Weikl A, Assmus KD, Neukum-Schmidt A, et al. Crataegus special extract WS
1442: Objective proof of efficacy in patients withy cardiac insufficiency (NYHA II).
Fortschr Med 1996;114:291–6.
- Tauchert M, Ploch M, Hübner W-D. Effectiveness of hawthorn extract LI 132
compared with the ACE inhibitor Captopril: Multicenter double-blind study with 132 patients
NYHA stage II. Münch Med Wochenschr 1994;132(suppl):S27–33.
- Hanack T, Brückel M-H. The treatment of mild stable forms of angina
pectoris using Crataegutt (R) Novo. Therapiewoche 1983;33:4331–3 [in
German].
- Brown DJ. Herbal Prescriptions for Better Health. Rocklin, CA: Prima
Publishing, 1996, 139–44.